Overview

Properties

Applications

Our Abpromise guarantee covers the use of ab57342 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB
  • Application notesWB: Use at a concentration of 1-5 µg/ml.


    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionCompetitive inhibitor of E2F-mediated transactivation activity. Impairs E2F-mediated cell-cycle progression from G(1) to S phase.
    • Tissue specificityPredominantly expressed in testis. Low level of expression in pancreas. Highly expressed in ovarian and colon cancer cell lines.
    • Sequence similaritiesBelongs to the E2F/DP family.
    • DomainThe potential DNA-binding domain differs in sequence from that of other DP family members and can not bind DNA.
    • Cellular localizationNucleus. Cytoplasm. Translocates to the nucleus on heterodimerization with E2F family members.
    • Information by UniProt
    • Database links
    • Alternative names
      • Cancer/testis antigen 30 antibody
      • CT30 antibody
      • DP4 antibody
      • E2F like protein antibody
      • E2F-like antibody
      • HCA661 antibody
      • Hepatocellular carcinoma-associated antigen 661 antibody
      • TFDP3 antibody
      • TFDP3_HUMAN antibody
      • Transcription factor Dp family member 3 antibody
      see all

    Anti-TFDP3 antibody images



    • Predicted band size : 38 kDa
      TFDP3 antibody (ab57342) at 1ug/lane + IMR-32 cell lysate at 25ug/lane.

    References for Anti-TFDP3 antibody (ab57342)

    ab57342 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab57342.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"